Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery Read more
AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery Read more